GS-0151

· Gilead Sciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GS-0151, covering 2026-01-21 to 2026-01-21. Get the full timeline:

Most recent: Clinical Trial Update: Study of GS-0151 in Participants With Rheumatoid Arthritis [Phase 1]